- Home
- HYB vs AMRN Comparison
HYB vs AMRN Comparison
Compare HYB & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYB
- AMRN
- Stock Information
- Founded
- HYB 1987
- AMRN 1989
- Country
- HYB United States
- AMRN Ireland
- Employees
- HYB N/A
- AMRN N/A
- Industry
- HYB Investment Managers
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- HYB Finance
- AMRN Health Care
- Exchange
- HYB Nasdaq
- AMRN Nasdaq
- Market Cap
- HYB 191.2M
- AMRN 189.2M
- IPO Year
- HYB 1999
- AMRN 1993
- Fundamental
- Price
- HYB $8.20
- AMRN $0.63
- Analyst Decision
- HYB
- AMRN Buy
- Analyst Count
- HYB 0
- AMRN 1
- Target Price
- HYB N/A
- AMRN N/A
- AVG Volume (30 Days)
- HYB 39.6K
- AMRN 1.6M
- Earning Date
- HYB 01-01-0001
- AMRN 02-27-2025
- Dividend Yield
- HYB 6.67%
- AMRN N/A
- EPS Growth
- HYB N/A
- AMRN N/A
- EPS
- HYB N/A
- AMRN N/A
- Revenue
- HYB N/A
- AMRN $241,021,000.00
- Revenue This Year
- HYB N/A
- AMRN N/A
- Revenue Next Year
- HYB N/A
- AMRN N/A
- P/E Ratio
- HYB N/A
- AMRN N/A
- Revenue Growth
- HYB N/A
- AMRN N/A
- 52 Week Low
- HYB $6.23
- AMRN $0.43
- 52 Week High
- HYB $7.41
- AMRN $1.37
- Technical
- Relative Strength Index (RSI)
- HYB 47.55
- AMRN 66.95
- Support Level
- HYB $8.15
- AMRN $0.43
- Resistance Level
- HYB $8.27
- AMRN $0.49
- Average True Range (ATR)
- HYB 0.06
- AMRN 0.04
- MACD
- HYB -0.00
- AMRN 0.01
- Stochastic Oscillator
- HYB 40.00
- AMRN 73.29
About HYB New America High Income Fund Inc. (The)
New America High Income Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide high current income while seeking to preserve stockholder capital by investing in a diversified portfolio of high-yield fixed-income securities. The Fund has a leveraged capital structure. The fund invests in fixed-maturity corporate debt securities that are rated less than the investment grade. Its portfolio of investment consists of investments in different sectors such as energy, financial, cable operators, healthcare, and others.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.